| # | Drug | Count |
|---|---|---|
| 0 | ALBUTEROL SULFATE | 49 |
| 1 | ACETAMINOPHEN | 34 |
| 2 | IBUPROFEN | 28 |
| 3 | LISINOPRIL | 28 |
| 4 | OMEPRAZOLE MAGNESIUM | 28 |
| 5 | FUROSEMIDE | 27 |
| 6 | ASPIRIN | 25 |
| 7 | IBUPFROFEN | 25 |
| 8 | IBUPROFEN 200 MG | 25 |
| 9 | IBUPROFEN 200MG | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NATURAL VEGETABLE LAXATIVE | 1 | 0.0244 |
| 1 | FORMALDEHYDE | 1 | 0.0164 |
| 2 | NAXITAMAB | 3 | 0.0120 |
| 3 | METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE | 2 | 0.0094 |
| 4 | BOTULISM ANTITOXIN HEPTAVALENT | 1 | 0.0078 |
| 5 | SUGAMMADEX SODIUM | 7 | 0.0053 |
| 6 | EUCALYPTOL, MENTHOL, UNSPECIFIED FORM, METHYL SALICYLATE, AND THYMOL | 1 | 0.0045 |
| 7 | LANADELUMAB-FLYO | 11 | 0.0034 |
| 8 | QUAZEPAM | 1 | 0.0033 |
| 9 | 1169 HYDROGEN PEROXIDE SPRAY | 1 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 102 |
| 1 | Corticosteroid [EPC] | 61 |
| 2 | Proton Pump Inhibitor [EPC] | 53 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 32 |
| 4 | Loop Diuretic [EPC] | 29 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 27 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 26 |
| 7 | Benzodiazepine [EPC] | 23 |
| 8 | Opioid Agonist [EPC] | 23 |
| 9 | Calcium Channel Blocker [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 15 | 0.0218 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 14 | 0.0058 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 11 | 0.0028 |
| 3 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 4 | Gadolinium-based Contrast Agent [EPC] | 5 | 0.0010 |
| 5 | Radiographic Contrast Agent [EPC] | 21 | 0.0008 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 9 | 0.0007 |
| 7 | Carnitine Analog [EPC] | 2 | 0.0005 |
| 8 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 9 | Contrast Agent for Ultrasound Imaging [EPC] | 3 | 0.0005 |